Pages that link to "Q56885139"
Jump to navigation
Jump to search
The following pages link to A Proportional Hazards Model for the Subdistribution of a Competing Risk (Q56885139):
Displaying 50 items.
- The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease (Q24613094) (← links)
- Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network (Q27852242) (← links)
- Invited commentary: Estimating population impact in the presence of competing events (Q28395101) (← links)
- Evaluation of BM cytomorphology after allo-SCT in patients with AML. (Q30318110) (← links)
- Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin (Q30419381) (← links)
- Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients (Q30427552) (← links)
- Regional variability in symptom-based MELD exceptions: a response to organ shortage? (Q30454559) (← links)
- Regression modeling of semicompeting risks data (Q31109934) (← links)
- Nonparametric tests for continuous covariate effects with multistate survival data (Q31146290) (← links)
- The protocols for the 10/66 dementia research group population-based research programme (Q33292026) (← links)
- Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413. (Q33322056) (← links)
- Marginal models for clustered time-to-event data with competing risks using pseudovalues (Q33550966) (← links)
- 1.5-2 cm tumor size was not associated with distant metastasis and mortality in small thyroid cancer: A population-based study (Q33551581) (← links)
- Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer (Q33701564) (← links)
- Quantile Regression for Left-Truncated Semicompeting Risks Data (Q33763813) (← links)
- Competing risks regression for stratified data. (Q33771054) (← links)
- Modelling competing risks data with missing cause of failure (Q33775842) (← links)
- Risk Factors of Mortality from All Asbestos-Related Diseases: A Competing Risk Analysis (Q33819781) (← links)
- An overview of techniques for linking high-dimensional molecular data to time-to-event endpoints by risk prediction models (Q33822746) (← links)
- Multicenter validation study of a transplantation-specific cytogenetics grouping scheme for patients with myelodysplastic syndromes (Q33847018) (← links)
- A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data (Q33894150) (← links)
- Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy (Q33928011) (← links)
- Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors (Q33937055) (← links)
- Polymorphisms in the base excision repair pathway and graft-versus-host disease (Q34063337) (← links)
- Predicting the absolute risk of dying from colorectal cancer and from other causes using population-based cancer registry data (Q34101336) (← links)
- Survival analysis in clinical trials: past developments and future directions (Q34113236) (← links)
- Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry (Q34436787) (← links)
- Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up (Q34477281) (← links)
- Tumor deposits in rectal adenocarcinoma after neoadjuvant chemoradiation are associated with poor prognosis (Q34502833) (← links)
- Joint modeling for cognitive trajectory and risk of dementia in the presence of death (Q34565740) (← links)
- Chronic kidney disease and the risk of end-stage renal disease versus death (Q34663602) (← links)
- Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry (Q34752982) (← links)
- Personalized estimates of breast cancer risk in clinical practice and public health (Q34815108) (← links)
- Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia (Q35015010) (← links)
- Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine–melphalan conditioning for treatment of mature T-cell lymphomas (Q35087581) (← links)
- Sex-based disparities in liver transplant rates in the United States (Q35093272) (← links)
- A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy (Q35096149) (← links)
- Diabetes: statins for microvascular complications-all but the kidney (Q35112065) (← links)
- Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer (Q35115736) (← links)
- Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis (Q35121804) (← links)
- Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes. (Q35152208) (← links)
- Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss (Q35172741) (← links)
- The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy (Q35207309) (← links)
- Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study (Q35262921) (← links)
- Physiological factors contributing to mobility loss over 9 years of follow-up—results from the InCHIANTI study (Q35451733) (← links)
- Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia. (Q35463268) (← links)
- Quality of care in patients with bladder cancer: a case report? (Q35541862) (← links)
- A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma (Q35678403) (← links)
- Cardiovascular Mortality in Type 2 Diabetes Patients with Incident Exposure to Insulin Glargine (Q35794125) (← links)
- Comorbidities, treatment and ensuing survival in men with prostate cancer (Q35888211) (← links)